References for this Review were identified from searches done by the authors over the past 30 years, as well as through searches of PubMed (from January 1980, until April 2011) with the search terms “complex regional pain syndrome”, “CRPS”, “reflex sympathetic dystrophy”, both alone and in combination with each of the following search terms: “epidemiology”, “incidence”, “risk factor”, “inflammation”, “sensory changes”, “cortical changes”, “sympathetic nervous system”, “sympathetically
ReviewClinical features and pathophysiology of complex regional pain syndrome
Introduction
Complex regional pain syndrome (CRPS) is characterised by pain in combination with sensory, autonomic, trophic, and motor abnormalities. A distinction is made between CRPS-1, in which a nerve lesion cannot be identified, and CRPS-2, in which it can. However, this distinction is not without criticism because bone fracture or surgery will damage peripheral nerve fibres but post-fracture and post-surgical CRPS are almost always classed as CRPS-1. Furthermore, pathological studies on chronic CRPS-1 limbs that have been amputated and skin biopsies of CRPS-1 limbs show degeneration of small (C and Aδ) nerve fibres,1, 2, 3 which serve nociceptive and autonomic functions. Whether nerve degeneration causes CRPS-1 remains to be established. Additionally, because other causes of neuropathic pain are frequently associated with a loss of C-fibre peripheral terminals,4 the specificity of these findings with respect to CRPS is questionable.
Our understanding of CRPS has increased substantially in the past decade. Three major pathophysiological pathways have been identified: aberrant inflammatory mechanisms, vasomotor dysfunction, and maladaptive neuroplasticity. The clinical heterogeneity of CRPS is indicative of between-individual variability in the activation of these pathways after tissue injury. Over the past 3–5 years, substantial developments have occurred in several areas of CRPS and their inter-relationships are only now being identified; these developments are rapidly changing our understanding of CRPS. In this Review, we present a multidisciplinary overview of CRPS that integrates findings across relevant fields and puts them into perspective. We discuss the clinical and epidemiological features of CRPS and the role of inflammation, vasomotor dysfunction, and maladaptive neuroplasticity in the development and persistence of the disorder.
Section snippets
Clinical presentation and diagnosis
Typically, patients with CRPS present after minor or moderate tissue injury (eg, a wrist fracture). In the acute phase, the injured limb is usually extremely painful, red, warm (although sometimes it quickly becomes cold)5 and swollen (figure 1A). Other features, which are also confined to the injured limb but not confined to the distribution of a specific nerve or nerve root, include allodynia (whereby usually non-painful stimuli evoke pain) and hyperalgesia (whereby painful stimuli evoke more
Epidemiology
Incidence of CRPS is unclear. Two population-based studies yielded very different data: 5·5 cases per 100 000 person-years in the USA7 and 26·2 per 100 000 person-years in the Netherlands.8 On the basis of these numbers, one might expect that 20 000–80 000 new cases of CRPS would be identified per year in the USA. Incidence increases with age until 70 years of age, and 3–4 times more women than men are affected.22, 23 The arm is affected in about 60% of cases and the leg in about 40%.22
Risk factors and prognostic determinants
Nearly everyone experiences tissue trauma, yet few develop CRPS, and the severity of trauma is not linked to the development of CRPS. Clearly, then, some individuals are more susceptible than others. Identification of risk factors other than injury alone might point to underlying biological mechanisms and assist in the development of preventive and treatment strategies. Epidemiological, genetic, and experimental studies have been done in an attempt to identify factors that modulate the risk of
The role of inflammation
Findings from in-vivo experiments in man show that even minor tissue trauma is sufficient to amplify cytokine signalling in the traumatised tissue.51, 52 Cytokines and nerve growth factor can excite nociceptors and induce long-term peripheral sensitisation.53, 54 Moreover, findings from in-vitro experiments suggest that cytokines55 and nerve growth factor56 enhance the release of inflammatory neuropeptides in primary afferent neurons. The activation of cutaneous nociceptors can induce
The role of vasomotor dysfunction
Vasomotor dysfunction is common in CRPS.80 The affected limb is usually warmer than the healthy limb early on, and colder than the healthy limb later on. This shift in temperature suggests that the activity in vasoconstrictor neurons changes over time in CRPS. This temperature shift has been investigated experimentally with central sympathetic vasoconstrictor reflexes induced by whole-body warming and cooling, and by respiratory stimuli.81, 82 Three distinct patterns of temperature change were
The role of the CNS
The CNS undergoes functional and structural changes in people with persistent pain and these changes are thought to be particularly important in CRPS.92 These persistent changes in the CNS lead to central sensitisation.93 The mechanisms of central sensitisation are not completely understood but might involve disinhibition of spinal and trigeminal nociceptive neurons or facilitation of nociceptive activity by excitatory neurons that project from the rostroventral medulla.94 Similar changes occur
Conclusions
Epidemiological, genetic, and experimental studies suggest that the pathophysiology of CRPS is multifactorial in nature and is characterised by an aberrant host response to tissue injury. We propose that (neurogenic) inflammation, nociceptive sensitisation, vasomotor dysfunction, and maladaptive neuroplasticity account for most or all of the clinical features of CRPS (figure 4). Interindividual differences in the extent to which these mechanisms are affected account for the clinical
Search strategy and selection criteria
References (132)
- et al.
Pathologic alterations of cutaneous innervation and vasculature in affected limbs from patients with complex regional pain syndrome
Pain
(2006) - et al.
Evidence of focal small-fiber axonal degeneration in complex regional pain syndrome-I (reflex sympathetic dystrophy)
Pain
(2006) - et al.
Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients
Lancet
(1993) - et al.
Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes
Pain
(2010) - et al.
Cutaneous sensory abnormalities in children and adolescents with complex regional pain syndromes
Pain
(2007) - et al.
Hemisensory impairment in patients with complex regional pain syndrome
Pain
(1999) - et al.
Patterns of spread in complex regional pain syndrome, type I (reflex sympathetic dystrophy)
Pain
(2000) - et al.
Urological symptomatology in patients with reflex sympathetic dystrophy
J Urol
(1996) - et al.
Validation of proposed diagnostic criteria (the “Budapest criteria”) for complex regional pain syndrome
Pain
(2010) - et al.
Complex regional pain syndrome: are the IASP diagnostic criteria valid and sufficiently comprehensive?
Pain
(1999)